COVID‐19 vaccination and psoriatic patients under biologics: real‐life evidence on safety and effectiveness from Italian vaccinated healthcare workers

COVID-19 outbreak had drastically modified the treatment of chronic inflammatory diseases (i.e. psoriasis) in terms of drug delivery, visits booking and patients' adherence. Furthermore, during lockdown several patients modified or even discontinued their anti-psoriatic treatments due to misinformation, COVID-phobia or even cabin fever syndrome experiencing a psoriatic flare and decreasing the overall daily functionality and quality of life.